| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 141 | JPS5543473B2 - | JP8719372 | 1972-09-01 | JPS5543473B2 | 1980-11-06 | |
| 142 | Poly cyclic amines and novel intermediates thereof | JP8150176 | 1976-07-10 | JPS5210201A | 1977-01-26 | EDOGAA ERIKUSUU |
| 143 | JPS4836184A - | JP8719372 | 1972-09-01 | JPS4836184A | 1973-05-28 | |
| 144 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | US16286914 | 2019-02-27 | US20190198928A1 | 2019-06-27 | Kei Shimamoto; Koji Abe; Shoji Shikita; Kazuhiro Miyoshi |
| The present invention provides a nonaqueous electrolytic solution capable of improving electrochemical characteristics in the case of using an energy storage device at a high temperature and at a high voltage and further capable of inhibiting the gas generation while maintaining a capacity retention rate after storage at a high temperature and at a high voltage and also provides an energy storage device using the same. Disclosed is a nonaqueous electrolytic solution having an electrolyte salt dissolved in a nonaqueous solvent, the nonaqueous electrolytic solution containing a carboxylic acid ester compound represented by the following general formula (I). In the formula, each of R1 and R2 independently represents a hydrogen atom, a —C(═O)—OR4 group, or the like, and R1 and R2 may be bonded to each other to form a ring structure. R3 represents a hydrogen atom or the like, and n represents an integer of 1 to 3. When n is 1, then L and R4 represent an alkyl group having 1 to 6 carbon atoms or the like; and when n is 2 or 3, then L represents an n-valent connecting group, X represents a —C(═O)— group, an —S(═O)— group, an —S(═O)2— group, an —S(═O)2—R5—S(═O)2— group or a CR6R7 group, R5 represents an alkylene group having 1 to 4 carbon atoms, and each of R6 and R7 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. | ||||||
| 145 | Method for Producing Fluorine-Containing Cyclopropane Carboxylic Acid Compound | US15741020 | 2016-06-24 | US20180186763A1 | 2018-07-05 | Takashi KASHIWABA; Takako YAMAZAKI; Shoko ISHII; Shunsuke MIMURA; Masanori FUSHIMI; Ryuichi OKAMOTO; Haruki KOBAYASHI; Manabu YASUMOTO |
| The present invention provides an industrially applicable method for production of a fluorine-containing cyclopropane carboxylic acid compound useful as an intermediate for pharmaceutical and agrichemical products. A fluorine-containing cyclopropane monoester is obtained by: forming a fluorine-containing cyclic sulfate with the use of a fluorine-containing dial compound and sulfuryl fluoride (as a cyclic sulfuric esterification step); reacting the fluorine-containing cyclic sulfate with a malonic diester, thereby forming a fluorine-containing cyclopropane diester (as a cyclopropanation step); and hydrolyzing the fluorine-containing cyclopropane diester (as a hydrolysis step). The fluorine-containing cyclopropane carboxylic acid compound, such as fluorine-containing cyclopropane monoester or its salt, can be obtained with high chemical and optical purity by mixing the fluorine-containing cyclopropane monoester with an amine and subjecting the resulting salt of the fluorine-containing cyclopropane monoester and amine to recrystallization purification. | ||||||
| 146 | Non-aqueous electrolyte solution for battery and lithium secondary battery | US14915550 | 2014-09-17 | US09899704B2 | 2018-02-20 | Masataka Miyasato; Satoko Fujiyama; Takashi Hayashi |
| A non-aqueous electrolyte solution for a battery includes: an additive A which is a compound represented by formula (I); and an additive B which is at least one selected from the group consisting of an aromatic compound having at least one of a halogen atom or an alkyl group and a carbamate, and which is a compound other than carbonates or a cyclic sulfates. In formula (I), R1 represents a group represented by formula (II) or a group represented by formula (III) and R2 represents H, a C1-6 alkyl group, a group represented by formula (II), or a group represented by formula (III); or R1 and R2 represent groups which combine to form a benzene ring or cyclohexyl ring. In formula (II), R3 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkyl halide group, a C1-6 alkoxy group, or a group represented by formula (IV). | ||||||
| 147 | Oxathiazine derivatives as antibacterial and anticancer agents | US14958225 | 2015-12-03 | US09624187B2 | 2017-04-18 | Rolf W. Pfirrmann |
| New oxathiazin-like compounds and their derivatives are useful as antineoplastic and antimicrobial agents. Compositions and methods of using oxathiazin-like compounds and their derivatives are disclosed. | ||||||
| 148 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | US14915550 | 2014-09-17 | US20160211551A1 | 2016-07-21 | Masataka MIYASATO; Satoko FUJIYAMA; Takashi HAYASHI |
| A non-aqueous electrolyte solution for a battery includes: an additive A which is a compound represented by formula (I); and an additive B which is at least one selected from the group consisting of an aromatic compound having at least one of a halogen atom or an alkyl group and a carbamate, and which is a compound other than carbonates or a cyclic sulfates. In formula (I), R1 represents a group represented by formula (II) or a group represented by formula (III) and R2 represents H, a C1-6 alkyl group, a group represented by formula (II), or a group represented by formula (III); or R1 and R2 represent groups which combine to form a benzene ring or cyclohexyl ring. In formula (II), R3 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkyl halide group, a C1-6 alkoxy group, or a group represented by formula (IV). | ||||||
| 149 | Cyclic (poly)Glycerol Sulphates and Preparation and Use Thereof | US14356512 | 2011-11-10 | US20150299158A1 | 2015-10-22 | Pascal Metivier; Yan Zhao; Zhaoyu Fan; Chenjiang Zhu |
| The present invention relates to novel cyclic sulphates of (poly)glycerol, particularly to the novel compound of 4-(hydroxymethyl)-1,3,2-dioxathiolane-2,2-dioxide. The present invention also relates to the preparation process of the cyclic sulphate compounds, and to the use thereof as an intermediate to prepare green surfactants containing sulphate groups. | ||||||
| 150 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | US14303641 | 2014-06-13 | US20140296344A1 | 2014-10-02 | Samuel FORTIN |
| There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhencers for radiotherapy of cancer. | ||||||
| 151 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | US13666002 | 2012-11-01 | US08816110B2 | 2014-08-26 | Samuel Fortin |
| There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhencers for radiotherapy of cancer. | ||||||
| 152 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | US14163682 | 2014-01-24 | US20140142324A1 | 2014-05-22 | Ayako KURAMOTO; Kuniaki OKAMOTO; Tsutomu WATAHIKI; Motoshige SUMINO |
| The present invention is directed to provide an efficient production method which is capable of not only obtaining a cyclic sulfonic acid ester (sultone) at low cost and in high yield, but also the sulfonic acid ester (sultone) stably even in a commercial scale. The present invention relates to a method for producing hydroxysultone comprising a first step where a diol having a specified structure and a thionyl halide are reacted to obtain a cyclic sulfite having a specified structure, and a second step where the cyclic sulfite is reacted with water or/and alcohol; a method for producing an unsaturated sultone having a specified structure comprising a third step where a hydroxylsultone having a specified structure is reacted with an acid halide or an acid anhydride to obtain an intermediate, subsequently the intermediate is treated with a base; as well as a cyclic sulfite having a specified structure. | ||||||
| 153 | CYCLIC SULFATE COMPOUND, NON-AQUEOUS ELECTROLYTE SOLUTION CONTAINING SAME, AND LITHIUM SECONDARY BATTERY | US13820969 | 2011-10-21 | US20130171514A1 | 2013-07-04 | Shigeru Mio; Mitsuo Nakamura; Kaichiro Haruta; Hidenobu Nogi; Satoko Fujiyama; Takashi Hayashi; Hidetoshi Tsunoda |
| A non-aqueous electrolyte solution containing a cyclic sulfate compound represented by formula (I) is provided, wherein in formula (I), R1 represents a group represented by formula (II) or a group represented by formula (III); R2 represents a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms, a group represented by formula (II), or a group represented by formula (III); and in formula (II), R3 represents a halogen atom, an alkyl group having from 1 to 6 carbon atoms, a halogenated alkyl group having from 1 to 6 carbon atoms, an alkoxy group having from 1 to 6 carbon atoms, or a group represented by formula (IV). | ||||||
| 154 | ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM USING THE SAME, PATTERN FORMING METHOD, ELECTRONIC DEVICE MANUFACTURING METHOD, AND ELECTRONIC DEVICE, EACH USING THE SAME | US13614797 | 2012-09-13 | US20130078433A1 | 2013-03-28 | Kaoru IWATO; Hidenori TAKAHASHI; Michihiro SHIRAKAWA |
| Provided are an actinic-ray-sensitive or a radiation-sensitive resin composition with greater residual film ratio and capable of suppressing pattern collapse and an occurrence of bridge defects after development, and a resist film, a pattern forming method, an electronic device manufacturing method, and an electronic device, each using the same. An actinic-ray-sensitive or radiation-sensitive resin composition includes a resin (P) having a repeating unit (a) represented by following General Formula (I), a compound (B) represented by any of following General Formulae (B-1) to (B-3), and a solvent, in General Formula (I), R0 represents a hydrogen atom or a methyl group, and R1, R2 and R3 each independently represent a straight chain or branched alkyl group. | ||||||
| 155 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | US13666002 | 2012-11-01 | US20130059911A1 | 2013-03-07 | Samuel FORTIN |
| There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhencers for radiotherapy of cancer. | ||||||
| 156 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | US12534439 | 2009-08-03 | US08119690B2 | 2012-02-21 | Samuel Fortin |
| There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhencers for radiotherapy of cancer. | ||||||
| 157 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | US13195233 | 2011-08-01 | US20110283463A1 | 2011-11-24 | Gregory Scot MIRACLE; George Douglas Hiler, II; Rebecca Massie Grey; Mark Robert Sivik; Ludwig Voelkel; Frank Dietsche; Christian Bittner |
| This invention relates to cleaning compositions comprising organic catalysts having enhanced enzyme compatibility and processes for making and using such cleaning compositions. | ||||||
| 158 | Process for preparation of 13,14-dihydro-PGF2 alpha derivatives | US11874218 | 2007-10-18 | US07897793B2 | 2011-03-01 | Jacek Martynow; Julita Szyc; Wieslaw Szelejewski; Osman Achmatowicz; Andrzej Kutner; Krzysztof Wiśniewski; Jerzy Winiarski; Oliwia Zegrocka-Stendel; Piotr Golebiewski |
| The invention relates to a process for the preparation of 13,14-dihydro-PGF2α derivatives of R or S configuration at carbon 15, represented by the general formula (I), wherein the identity of the substituents is defined in the description. Compounds of the formula (I) are valuable biologically-active substances or intermediates in the preparation thereof. The invention especially relates to the process for preparation of 13,14-dihydro-15(R)-17-substituted-18,19,20-trinor-PGF2α, i.e., latanoprost. | ||||||
| 159 | CYCLIC SULFONIUM SALT, METHOD FOR PRODUCTION OF CYCLIC SULFONIUM SALT, AND GLYCOSIDASE INHIBITOR | US12522111 | 2008-01-04 | US20100063302A1 | 2010-03-11 | Osamu Muraoka; Genzoh Tanabe |
| Disclosed are: kotalanol which has an inhibitory activity on a glucosidase; a method for producing kotalanol or a cyclic sulfonium salt which is an analogue to kotalanol by an organic synthesis technique; a cyclic sulfonium salt produced by the method; a glucosidase inhibitor comprising the compound; an anti-diabetic agent or an anti-diabetic food comprising the glucosidase inhibitor. A sulfonium compound including kotalanol can be produced by coupling a thio-sugar synthesized from D-xylose (e.g., a compound having a cyclic structure composed of 4 carbon atoms and one sulfur atom, such as 1,4-dideoxy-1,4-epithio-D-arabinitol) with a heptitol cyclic sulfate ester having a protected hydroxyl group and synthesized from a pentose (D-xylose, D-ribose, D-arabinose, D-lyxose, L-xylose, L-ribose, L-arabinose or L-lyxose) to produce a cyclic sulfonium salt having a protected hydroxyl group, and then deprotecting the hydroxyl group. | ||||||
| 160 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | US12468907 | 2009-05-20 | US20090222999A1 | 2009-09-10 | Gregory Scot Miracle; George Douglas Hiler, II; Rebecca Massie Grey; Mark Robert Sivik; Ludwig Voelkel; Frank Dietsche; Christian Bittner |
| This invention relates to cleaning compositions comprising organic catalysts having enhanced enzyme compatibility and processes for making and using such cleaning compositions. | ||||||
QQ群二维码
意见反馈
意见反馈